2.5. Cilostazol Inhibits De Novo Lipogenesis (DNL) in the Liver of NAFLD Mice by Activating AMPK-ACC1/SCD1 Pathway. This evidence concerns the gene SCD and metabolic dysfunction-associated steatotic liver disease.